Variant report
Variant | nsv582065 |
---|---|
Chromosome Location | chr2:57385309-57397423 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:57395336..57397407-chr2:57403214..57404804,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12713333 | chr2:57385309-57385310 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs532039780 | chr2:57385358-57385359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552092443 | chr2:57385361-57385362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114462436 | chr2:57385366-57385367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17048697 | chr2:57385399-57385400 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs77963556 | chr2:57387633-57387634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs398060209 | chr2:57387636-57387637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543753236 | chr2:57387655-57387656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs71393562 | chr2:57387713-57387714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369011200 | chr2:57387714-57387715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557522097 | chr2:57387718-57387719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577375470 | chr2:57387767-57387768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371005958 | chr2:57387778-57387779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs17048702 | chr2:57387779-57387780 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs559607813 | chr2:57387783-57387784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528620573 | chr2:57387789-57387790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532985868 | chr2:57387790-57387791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188745733 | chr2:57387798-57387799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562109832 | chr2:57387813-57387814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530814981 | chr2:57387815-57387816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550901058 | chr2:57387830-57387831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570577816 | chr2:57387847-57387848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141445678 | chr2:57387850-57387851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs966115 | chr2:57387855-57387856 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs546643361 | chr2:57387874-57387875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566431777 | chr2:57387875-57387876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs117922491 | chr2:57387898-57387899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554942167 | chr2:57387966-57387967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568555166 | chr2:57387984-57387985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537308660 | chr2:57388001-57388002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557374651 | chr2:57388035-57388036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566242976 | chr2:57388042-57388043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113411560 | chr2:57388046-57388047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112855359 | chr2:57388101-57388102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs966116 | chr2:57388104-57388105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs193034062 | chr2:57388124-57388125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115832318 | chr2:57388195-57388196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542381191 | chr2:57388220-57388221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528850512 | chr2:57388246-57388247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs76518777 | chr2:57388256-57388257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544131227 | chr2:57388257-57388258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs117328720 | chr2:57388318-57388319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544464404 | chr2:57388343-57388344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7562542 | chr2:57388379-57388380 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs185173439 | chr2:57388383-57388384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546458779 | chr2:57388423-57388424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200224382 | chr2:57388442-57388443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190618822 | chr2:57388460-57388461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369294725 | chr2:57388466-57388467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372932268 | chr2:57388475-57388476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:57385000-57385400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr2:57387600-57389600 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr2:57388000-57389400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr2:57389400-57390400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
5 | chr2:57390400-57392000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr2:57395400-57396200 | Enhancers | Muscle Satellite Cultured Cells | -- |